Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 50 of 59, showing 10 Applications out of 584 total, starting on record 491, ending on 500

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

491.

ECCT/22/01/06   AIKILI Technology
    Feasibility and accuracy of nanosensor-based breast cancer diagnosis at the point-of-care-AIKILI technology       
Principal Investigator(s)
1. Laura Kelley Kelley
Site(s) in Kenya
Aga Khan University Hospital, Nairobi.
 
21-03-2022 View

492.

ECCT/17/04/01   Odón Device for assisted vaginal delivery
    Feasibility, safety and preliminary efficacy study of a new device (Odón  Device) for assisted vaginal delivery   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
Kenyatta National Hospital
 
22-06-2017 View

493.

ECCT/17/03/03   FLACSAM
    First Line Antimicrobials in Children with Complicated Severe Acute Malnutrition   
Principal Investigator(s)
1. James Berkley
Site(s) in Kenya
1. Kilifi County Hospital (Kilifi county)
2. Coast General Hospital (Mombasa county)
3. Mbagathi Hospital (Nairobi City county)
 
21-06-2017 View

494.

ECCT/25/02/02   HPV vaccine feasibility study
    Generating local data on HPV vaccination impact and training needs at the level of vaccine implementers – A feasibility study   
Principal Investigator(s)
1. Prof Kenneth Ngure
Site(s) in Kenya
KEMRI-CCR PHRD( (THIKA) PROJECT
 
29-04-2025 View

495.

ECCT/15/12/04   Hormones and Economic Choice
    Hormones and Economic Choice: Evaluating the Effects of Hydrocortisone Administration on Economic Decision Making, Psychology and Social Behavior among Adult Males in Nairobi, Kenya   
Principal Investigator(s)
1. Johannes Haushofer
Site(s) in Kenya
Busara Center for Behavioral Economics
 
11-03-2016 View

496.

ECCT/25/11/02   DELIVER-02
    IGHID 12430/DELIVER-02 - A PHASE 1, OPEN LABEL,STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF MGD014 AND MGD020 WITH A LATENCY REVERSAL AGENT VERSUS TEMPORARY TREATMENT INTERRUPTION IN PERSONS WITH HIV-1 ON ANTIRETROVIRAL THERAPY   
Principal Investigator(s)
1. Deborah Chepngeno Langat
Site(s) in Kenya
1. Kericho Clinical Research Center (Kericho CRC), Kericho, (Kericho county)
2. MOI UNIVERSITY CLINICAL RESEARCH CENTRE (MUCRC), ELDORET (Uasin Gishu county)
 
25-06-2026 View

497.

ECCT/26/04/02   IGHID 12430/DELIVER-02
    IGHID12430/DELIVER-02 - A PHASE 1, OPEN LABEL,STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF MGD014 AND MGD020 WITH A LATENCY REVERSAL AGENT VERSUS TEMPORARY TREATMENT INTERRUPTION IN PERSONS WITH HIV-1 ON ANTIRETROVIRAL THERAPY   
Principal Investigator(s)
1. Charity Wambui Kanyoro
Site(s) in Kenya
1. Moi University Clinical Research Centre(MUCRC), Eldoret, Kenya (Uasin Gishu county)
2. Kericho Clinical Research Center (Kericho CRC), Kericho, (Kericho county)
 
25-06-2026 View

498.

ECCT/18/05/02   KINGA Study
    Immunogenetic Modulators of Mucosal Protection from HIV-1: The Kinga Study   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR - Partners in Health Research & Development (PHRD) Thika Site.
 
26-07-2018 View

499.

ECCT/12/02/02   HIV/HPV-Adolescent Study
    Immunogenicity and Safety of quadrivalent human Papillomavirus Vaccine in HIV-Infected pre-adolescent girls and boys in Kenya.   
Principal Investigator(s)
1. Dr. Nelly Rwamba Mugo
Site(s) in Kenya
Thika
 
22-05-2012 View

500.

ECCT/17/08/07   Tambua Mapema Plus
    Impact of a novel HIV-1 RNA testing intervention to detect acute and prevalent HIV infection and reduce HIV transmission – Tambua Mapema Plus   
Principal Investigator(s)
1. Eduard J Sanders
2. Susan M Graham
Site(s) in Kenya
KEMRI Mtwapa Research Clinic
 
25-08-2017 View